QA: AMICUS THERAPEUTICS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178879_2023_AMICUS_THERAPEUTICS_INC.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001178879, AMICUS THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 423,816,000
1 IntangibleAssetsNetIncludingGoodwill 220,797,000
2 PropertyPlantAndEquipmentNet 30,778,000
3 remainder_Assets 48,776,000
4 LiabilitiesCurrent 139,018,000
5 LiabilitiesNoncurrent 60,517,000
6 remainder_Liabilities 401,585,000
7 CostOfGoodsAndServicesSold 38,599,000
8 SellingGeneralAndAdministrativeExpense 213,041,000
9 ResearchAndDevelopmentExpense 276,677,000
10 remainder_Expenses 44,684,000
11 remainder_Revenues 329,233,000
12 remainder_NetIncome 7,200,000
13 remainder_ComprehensiveNetIncome -17,086,000
  yvar yval
0 Assets 724,167,000
1 Liabilities 601,120,000
2 Expenses 573,001,000
3 Revenues 329,233,000
4 StockholdersEquity 123,047,000
5 NetIncome -236,568,000
6 ComprehensiveNetIncome -245,111,000
7 BaseVar 1,125,903,500
8 EconomicCapitalRatio -0.0505

Edgar->Model Mapping

Feature Distribution

Change over Time